HypertensionDiabetesAtrial FibrillationDyslipidemiaSmokingPhysical InactivityObesity and Overweight
Investigational drug(s) / intervention(s)
Wearable Devices
Wearable Devices: Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.
Study summary
The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke
Eligibility
Sex
ALL
Min age
30 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Diagnosed with hypertension;
2. Diagnosed with diabetes;
3. Diagnosed with atrial fibrillation;
4. Smoking subjects;
5. Physical inactive subjects；
6. Obesity and overweight subjects;
7. Must be able to use smart wearable devices.
Exclusion Criteria:
1. Diagnosed with malignancies;
2. Diagnosed with psychiatric disorders;
3. Diagnosed with cognitive impairment;
4. Unable to operate smart wearable devices.
Primary outcome measure(s)
medication adherence and risk factor control rates — 6 months 1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.
Trial sites (1)
Facility
City
Region
Status
Affiliated Hospital of Nantong University
Nantong
Jiangsu
Recruiting
More Affiliated Hospital of Nantong University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.